B cells promote tumor immunity against B16F10 melanoma

American Journal of Pathology

Volumn 184, Issue 11, 2014, Pages 3120-3129

  Kobayashi, Tadahiro ^a   Hamaguchi, Yasuhito ^a   Hasegawa, Minoru ^b   Fujimoto, Manabu ^c   Takehara, Kazuhiko ^a   Matsushita, Takashi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; B CELL LINKER PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CANCER GROWTH; CANCER MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; INGUINAL LYMPH NODE; MELANOMA; MELANOMA B16F10; MOUSE; MOUSE MODEL; NONHUMAN; SPLEEN CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR VOLUME; WILD TYPE; ANIMAL; EXPERIMENTAL MELANOMA; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; FEMALE; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT;

EID: 84908181358     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.07.003     Document Type: Article

References (41)

1. B.H. Nelson CD20+ B cells: the other tumor-infiltrating lymphocytes J Immunol 185 2010 4977 4982
2. V. Lampropoulou, E. Calderon-Gomez, T. Roch, P. Neves, P. Shen, U. Stervbo, P. Boudinot, S.M. Anderton, and S. Fillatreau Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity Immunol Rev 233 2010 146 161
3. J.D. Bouaziz, K. Yanaba, and T.F. Tedder Regulatory B cells as inhibitors of immune responses and inflammation Immunol Rev 224 2008 201 214
4. C. Mauri, D. Gray, N. Mushtaq, and M. Londei Prevention of arthritis by interleukin 10-producing B cells J Exp Med 197 2003 489 501
5. S. Shah, A.A. Divekar, S.P. Hilchey, H.M. Cho, C.L. Newman, S.U. Shin, H. Nechustan, P.M. Challita-Eid, B.M. Segal, K.H. Yi, and J.D. Rosenblatt Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells Int J Cancer 117 2005 574 586
6. Z. Qin, G. Richter, T. Schüler, S. Ibe, X. Cao, and T. Blankenstein B cells inhibit induction of T cell-dependent tumor immunity Nat Med 4 1998 627 630
7. C. João, B.M. Ogle, C. Gay-Rabinstein, J.L. Platt, and M. Cascalho B cell-dependent TCR diversification J Immunol 172 2004 4709 4716
8. V. Moulin, F. Andris, K. Thielemans, C. Maliszewski, J. Urbain, and M. Moser B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation J Exp Med 192 2000 475 482
9. D.S. Ritchie, J. Yang, I.F. Hermans, and F. Ronchese B-lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells Scand J Immunol 60 2004 543 551
10. A. Crawford, M. Macleod, T. Schumacher, L. Corlett, and D. Gray Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells J Immunol 176 2006 3498 3506
11. D.J. DiLillo, K. Yanaba, and T.F. Tedder B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice J Immunol 184 2010 4006 4016
12. R. Pappu, A.M. Cheng, B. Li, Q. Gong, C. Chiu, N. Griffin, M. White, B.P. Sleckman, and A.C. Chan Requirement for B cell linker protein (BLNK) in B cell development Science 286 1999 1949 1954
13. H. Jumaa, B. Wollscheid, M. Mitterer, J. Wienands, M. Reth, and P.J. Nielsen Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65 Immunity 11 1999 547 554
14. Y. Minegishi, J. Rohrer, E. Coustan-Smith, H.M. Lederman, R. Pappu, D. Campana, A.C. Chan, and M.E. Conley An essential role for BLNK in human B cell development Science 286 1999 1954 1957
15. K. Hayashi, R. Nittono, N. Okamoto, S. Tsuji, Y. Hara, R. Goitsuka, and D. Kitamura The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells Proc Natl Acad Sci U S A 97 2000 2755 2760
16. G. Jin, Y. Hamaguchi, T. Matsushita, M. Hasegawa, D. Le Huu, N. Ishiura, K. Naka, A. Hirao, K. Takehara, and M. Fujimoto B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells J Allergy Clin Immunol 131 2013 1674 1682
17. D. Le Huu, T. Matsushita, G. Jin, Y. Hamaguchi, M. Hasegawa, K. Takehara, and M. Fujimoto IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease J Invest Dermatol 132 2012 2752 2761
18. S. Sakaguchi Regulatory T cells: key controllers of immunologic self-tolerance Cell 101 2000 455 458
19. D. Dieckmann, H. Plottner, S. Berchtold, T. Berger, and G. Schuler Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood J Exp Med 193 2001 1303 1310
20. E.M. Shevach CD4+ CD25+ suppressor T cells: more questions than answers Nat Rev Immunol 2 2002 389 400
21. N. Kobayashi, N. Hiraoka, W. Yamagami, H. Ojima, Y. Kanai, T. Kosuge, A. Nakajima, and S. Hirohashi FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis Clin Cancer Res 13 2007 902 911
22. V. Watt, F. Ronchese, and D. Ritchie Resting B cells suppress tumor immunity via an MHC class-II dependent mechanism J Immunother 30 2007 323 332
23. J.S. Nielsen, R.A. Sahota, K. Milne, S.E. Kost, N.J. Nesslinger, P.H. Watson, and B.H. Nelson CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer Clin Cancer Res 18 2012 3281 3292
24. M.S. Asano, and R. Ahmed CD8 T cell memory in B cell-deficient mice J Exp Med 183 1996 2165 2174
25. S. Inoue, W.W. Leitner, B. Golding, and D. Scott Inhibitory effects of B cells on antitumor immunity Cancer Res 66 2006 7741 7747
26. J.A. Coronella-Wood, and E.M. Hersh Naturally occurring B-cell responses to breast cancer Cancer Immunol Immunother 52 2003 715 738
27. H.P. Dong, M.B. Elstrand, A. Holth, I. Silins, A. Berner, C.G. Trope, B. Davidson, and B. Risberg NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma Am J Clin Pathol 125 2006 451 458
28. S. Lindner, K. Dahlke, K. Sontheimer, M. Hagn, C. Kaltenmeier, T.F. Barth, T. Beyer, F. Reister, D. Fabricius, R. Lotfi, O. Lunov, G.U. Nienhaus, T. Simmet, R. Kreienberg, P. Möller, H. Schrezenmeier, and B. Jahrsdörfer Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells Cancer Res 73 2013 2468 2479
29. E. Wieckowski, G.Q. Wang, B.R. Gastman, L.A. Goldstein, and H. Rabinowich Granzyme B-mediated degradation of T-cell receptor zeta chain Cancer Res 62 2002 4884 4889
30. K. Milne, M. Köbel, S.E. Kalloger, R.O. Barnes, D. Gao, C.B. Gilks, P.H. Watson, and B.H. Nelson Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors PLoS One 4 2009 e6412
31. D. Rodríguez-Pinto B cells as antigen presenting cells Cell Immunol 238 2005 67 75
32. J.D. Bouaziz, K. Yanaba, G.M. Venturi, Y. Wang, R.M. Tisch, J.C. Poe, and T.F. Tedder Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice Proc Natl Acad Sci U S A 104 2007 20878 20883
33. A. Rivera, C.C. Chen, N. Ron, J.P. Dougherty, and Y. Ron Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations Int Immunol 13 2001 1583 1593
34. Y. Xiu, C.P. Wong, J.D. Bouaziz, Y. Hamaguchi, Y. Wang, S.M. Pop, R.M. Tisch, and T.F. Tedder B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions J Immunol 180 2008 2863 2875
35. F.D. Batista, and M.S. Neuberger Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate Immunity 8 1998 751 759
36. M.H. Hansen, H. Nielsen, and H.J. Ditzel The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells Proc Natl Acad Sci U S A 98 2001 12659 12664
37. B. Kotlan, P. Simsa, J.L. Teillaud, W.H. Fridman, J. Toth, M. McKnight, and M.C. Glassy Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes J Immunol 175 2005 2278 2285
38. M. Yasuda, M. Mizukami, T. Hanagiri, Y. Shigematsu, T. Fukuyama, Y. Nagata, T. So, Y. Ichiki, M. Sugaya, M. Takenoyama, K. Sugio, and K. Yasumoto Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer Anticancer Res 26 2006 3607 3611
39. A.B. Bakker, M.W. Schreurs, A.J. de Boer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes J Exp Med 179 1994 1005 1009
40. Y. Kawakami, S. Eliyahu, K. Sakaguchi, P.F. Robbins, L. Rivoltini, J.R. Yannelli, E. Appella, and S.A. Rosenberg Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes J Exp Med 180 1994 347 352
41. T. Moutai, H. Yamana, T. Nojima, and D. Kitamura A novel and effective cancer immunotherapy mouse model using antigen-specific B cells selected in vitro PLoS One 9 2014 e92732